1. Ergönül Ö. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006;6:203-14. [ DOI:10.1016/S1473-3099(06)70435-2] 2. World Health Organization. Crimean-Congo haemorrhagic fever [2010]. Available from: http://www.who.int/mediacentre/factsheets/fs208/en/. 3. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004;64:145-60. [ DOI:10.1016/j.antiviral.2004.08.001] 4. Gozalan A, Esen B, Fitzner J, Sua Tapar F, Peker Ozkan A, Georges-Courbot M-C, et al. Crimean-Congo haemorrhagic fever cases in Turkey. Scand J Infect Dis 2007;39:332-6. [ DOI:10.1080/00365540601053014] 5. Garcia S, Chinikar S, Coudrier D, Billecocq A, Hooshmand B, Crance J, et al. Evaluation of a Crimean-Congo hemorrhagic fever virus recombinant antigen expressed by Semliki Forest suicide virus for IgM and IgG antibody detection in human and animal sera collected in Iran. J Clin Virol 2006;35:154-9. [ DOI:10.1016/j.jcv.2005.02.016] 6. Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 1995;346:472-5. [ DOI:10.1016/S0140-6736(95)91323-8] 7. Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infec 2006;52:378-82. [ DOI:10.1016/j.jinf.2005.07.015] 8. Mardani M, Rahnavardi M, Sharifi-Mood B. Current treatment of Crimean-Congo hemorrhagic fever in children. Expert Rev Anti Infect Ther 2010;8:911-8. [ DOI:10.1586/eri.10.67] 9. Tezer H, Polat M. Diagnosis of Crimean-Congo hemorrhagic fever. Expert Rev Anti Infect Ther 2015;13:555-66. [ DOI:10.1586/14787210.2015.1021782] 10. Mostafavi E, Pourhossein B, Chinikar S. Clinical symptoms and laboratory findings supporting early diagnosis of Crimean‐Congo hemorrhagic fever in Iran. J Med Virol 2014;86:1188-92. [ DOI:10.1002/jmv.23922] 11. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J 2008;27(6):561-3. [ DOI:10.1097/INF.0b013e3181673c28] 12. Izadi S, Naieni KH, Madjdzadeh SR, Nadim A. Crimean-Congo hemorrhagic fever in Sistan and Baluchestan Province of Iran, a case-control study on epidemiological characteristics. Int J Infect Dis 2004;8:299-306. [ DOI:10.1016/j.ijid.2003.10.008] 13. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 1979;15:307-417. [ DOI:10.1093/jmedent/15.4.307] 14. Saidi S, Casals J, Faghih M. Crimean hemorrhagic fever-Congo (CHF-C) virus antibodies in man, and in domestic and small mammals, in Iran. Am J Trop Med Hyg 1975;24:353-7. [ DOI:10.4269/ajtmh.1975.24.353] 15. Sureau P, Klein J, Casals J, Digoutte J, Salaun J, Piazak N, et al. Isolation of Thogoto, Wad Medani, Wanowrie and Crimean-Congo haemorrhagic fever viruses from ticks of domestic animals in Iran. Annales de Virologie, E 1980;131):185-200. [ DOI:10.1016/0769-2617(80)90032-5] 16. Izadi S, Holakouie-Naieni K, Majdzadeh SR, Chinikar S, Nadim A, Rakhshani F, et al. Seroprevalence of Crimean-Congo hemorrhagic fever in Sistan-va-Baluchestan province of Iran. Jpn J Infect Dis 2006;59:326. [ DOI:10.7883/yoken.JJID.2006.326] 17. Aslani D, Salehi-Vaziri M, Baniasadi V, Jalali T, Azad-Manjiri S, Mohammadi T, et al. Crimean-Congo hemorrhagic fever among children in Iran. Arch Virol 2017;162:721-5. [ DOI:10.1007/s00705-016-3162-7] 18. Bijani B, Mardani M. Clinico-Epidemiological Feature and Outcome Analysis of Hemorrhagic Form of Crimean -Congo Hemorhagic Fever (CCHF) in Iran. 41st Annual Meeting of IDSA; San Diego- United States; 2003. p.763. 19. Nadeem M, Ali N, Anwar M, Hussain I, Mohammad T, Hayee A. A comparison of clinical diagnosis & Serological diagnosis in an epidemic of Crimean-Congo Haemorrhagic Fever. Pak J Med Sci 2003;19:247-51. 20. Chinikar S, Ghiasi SM, Moradi M, Bouloy M, Haeri A, editors. Trend of Crimean-Congo Hemorrhagic Fever (CCHF) in Iranian Children. 28th Annual Meeting of European Society for Pediatric Infectious Diseases, Nice, France; 2010. [ DOI:10.1203/00006450-201011001-00902] 21. Crimean-Congo hemorrhagic fever--Republic of South Africa. MMWR Morb Mortal Wkly Rep 1985;34:94, 9-101. 22. Altaf A, Luby S, Jamil A, Najam A, Aamir Z, Khan J, et al. Outbreak of Crimean‐Congo haemorrhagic fever in Quetta, Pakistan: contact tracing and risk assessment. Trop Med Int Health 1998;3:878-82. [ DOI:10.1046/j.1365-3156.1998.00318.x] 23. Athar MN, Baqai HZ, Ahmad M, Khalid MA, Bashir N, Ahmad AM, et al. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002. Am J Trop Med Hyg 2003;69:284-7. [ DOI:10.4269/ajtmh.2003.69.284] 24. Izadi S, Salehi M, Holakouie-Naieni K, Chinikar S. The risk of transmission of Crimean-Congo hemorrhagic fever virus from human cases to first-degree relatives. Jpn J Infect Dis 2008;61:494-6. [ DOI:10.7883/yoken.JJID.2008.494] 25. Saijo M, Tang Q, Shimayi B, Han L, Zhang Y, Asiguma M, et al. Possible horizontal transmission of Crimean-Congo hemorrhagic fever virus from a mother to her child. Jpn J Inf Dis 2004;57:55-7. [ DOI:10.7883/yoken.JJID.2004.55] 26. Kara A. Crimean Congo haemorrhagic fever. Turk Arch Ped 2008;43:108-18. 27. Kaya A, Engin A, Güven AS, İçağasıoğlu FD, Cevit Ö, Elaldı N, et al. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods. Int J Infect Dis 2011;15:e449-52. [ DOI:10.1016/j.ijid.2011.03.007] 28. Swanepoel R, Shepherd A, Leman P, Shepherd S, McGillivray G, Erasmus M, et al. Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. m J Trop Med Hyg 1987;36:120-32. [ DOI:10.4269/ajtmh.1987.36.120] 29. Gubler DJ, Reiter P, Ebi KL, Yap W, Nasci R, Patz JA. Climate variability and change in the United States: potential impacts on vector-and rodent-borne diseases. nviron Health Perspect 2001;109:S223-33. [ DOI:10.1289/ehp.109-1240669] 30. Borio L, Inglesby T, Peters C, Schmaljohn AL, Hughes JM, Jahrling PB, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002;287:2391-405. [ DOI:10.1001/jama.287.18.2391] 31. Swanepoel R, Gill D, Shepherd A, Leman P, Mynhardt J, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989;11:S794-800. [ DOI:10.1093/clinids/11.Supplement_4.S794] 32. Keshtkar-Jahromi M, Sajadi MM, Ansari H, Mardani M, Holakouie-Naieni K. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res 2013;100:20-8. [ DOI:10.1016/j.antiviral.2013.07.007] 33. Chinikar S, Goya M, Shirzadi M, Ghiasi S, Mirahmadi R, Haeri A, et al. Surveillance and Laboratory Detection System of Crimean‐Congo Haemorrhagic Fever in Iran. Transbound Emerg Dis 2008;55:200-204. [ DOI:10.1111/j.1865-1682.2008.01028.x] 34. Adam IA, Mahmoud MA, Aradaib IE. A seroepidemiological survey of Crimean Congo hemorrhagic fever among Cattle in North Kordufan State, Sudan. Virol J 2013;10:178. [ DOI:10.1186/1743-422X-10-178] 35. Lazarev V. Treatment of Crimean hemorrhagic fever patients with convalescent sera. Arboviruses Mater 1969;16:142-3. 36. Swanepoel R, Leham P, Abbott J, Burt F, Grobbelaar A, editors. Epidemiology, diagnosis, clinical pathology and treatment of Crimean-Congo hemorrhagic fever (CCHF) in South Africa. Proceedings and Abstracts of the VIIth International Congress of Virology, Berlin; 1990. 37. Wray SK, Gilbert BE, Knight V. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res 1985;5:39-48. [ DOI:10.1016/0166-3542(85)90013-0] 38. Wray SK, Gilbert BE, Noall MW, Knight V. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Res 1985;5:29-37. [ DOI:10.1016/0166-3542(85)90012-9] 39. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986;314:20-6. [ DOI:10.1056/NEJM198601023140104] 40. Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep 1988;37:S1-16. 41. van de Wal BW, Joubert JR, van Eeden PJ, King JB. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part IV. Preventive and prophylactic measures. S Afr Med J 1985;68:729-32. 42. Ergonul O. DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009 43. 58: 238-244): Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever. J Infect 2009;59:284-6. [ DOI:10.1016/j.jinf.2009.08.006] 44. Erduran E, Bahadir A, Palanci N, Gedik Y. The treatment of crimean-congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma. J Pediatr Hematol Oncol 2013;35:e19-24. [ DOI:10.1097/MPH.0b013e3182706444] 45. Update: management of patients with suspected viral hemorrhagic fever--United States. MMWR Morb Mortal Wkly Rep 1995;44:475-9. 46. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006;52:207-15. [ DOI:10.1016/j.jinf.2005.05.003] 47. Roberts SS, Miller RK, Jones JK, Lindsay KL, Greene MF, Maddrey WC, et al. The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009. Birth Defects Res A Clin Mol Teratol 2010;88:551-9. [ DOI:10.1002/bdra.20682] 48. Tezer H, Ozkaya-Parlakay A, Gulhan B, Kanik-Yuksek S. Ribavirin use in pediatric patients with Crimean Congo Hemorrhagic Fever: is it really necessary? Braz J Infect Dis 2016;20:222-3. [ DOI:10.1016/j.bjid.2015.11.012] 49. Perk O, Emeksiz S, Ozcan S, Meral G. Crimean-Congo hemorrhagic fever: A pediatric case responding to plasmapheresis treatment. Transfus Apher Sci 2021;60:103215. [ DOI:10.1016/j.transci.2021.103215] 50. Sohail A, Iqbal AA, Sahini N, Chen F, Tantawy M, Waqas SFH, et al. Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. PLoS Pathog 2022;18:e1010219. [ DOI:10.1371/journal.ppat.1010219] 51. Farag NS, Breitinger U, Breitinger HG, El Azizi MA. Viroporins and inflammasomes: A key to understand virus-induced inflammation. Int J Biochem Cell Biol 2020;122:105738. [ DOI:10.1016/j.biocel.2020.105738] 52. Sawa T, Akaike T. What triggers inflammation in COVID-19? Elife 2022;11:e76231. [ DOI:10.7554/eLife.76231] 53. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000;6:601-8. [ DOI:10.3201/eid0606.000608] 54. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 2006;36:272-6. [ DOI:10.1016/j.jcv.2006.04.007] 55. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006;193:941-4. [ DOI:10.1086/500836] |
